Natera Inc

Research Natera Inc (NTRA) on Bullrun: market cap USD 39.00B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNTRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 39.00B
• Financial periodFY2025
• RevenueUSD 2.31B
• Revenue growth35.9%
• Net income-USD 208.16M
• Free cash flowUSD 109.11M

Valuation Snapshot

latest market cap is USD 39.00B.

About Natera Inc

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.

Frequently asked questions

What is Natera Inc's market cap?

Natera Inc's market capitalization is USD 39.00B.

What does Natera Inc do?

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.